Neurological Autoantibody Prevalence in Epilepsy on Unknown EtiologyJAMA Neurol 74:397-402,384, Dubey, D.,et al, 2017
Alemtuzumab for Multiples Sclerosis: Who and When to treat?Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012